Compare SMX Security Matters plc (SMX) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SMX Security Matters plc vs 10X Genomics Inc — how do they compare? SMX Security Matters plc trades at $16 (market cap $17.04M), while 10X Genomics Inc trades at $58.55 (market cap $7.61B). The key difference: 10X Genomics Inc is far larger — about 446.6× SMX Security Matters plc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, SMX Security Matters plc nearer its low. Which is the better fit depends on your goals.
| SMX | TXG | |
|---|---|---|
Market Cap | $17.04M | $7.61B |
Sector | Technology | Health |
52-Week High | $103.71K | $58.57 |
52-Week Low | $12.87 | $11.34 |
Enterprise Value | -$14.29M | $7.14B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SMX trades at $15.77, down 0.19% with a bearish technical signal from moving averages. The company reported significant losses with -$169.18M net income for 2025 and negative ROE of -819.22%, though recent news highlights balance sheet strengthening and commercialization progress in recycled plastics traceability. Cash flow remains dependent on financing activities.
Outlook remains challenged by persistent losses and negative profitability metrics, offset by positioning in the growing recycled plastics verification market. Key risks include execution on commercialization and cash burn. Institutional sentiment appears mixed amid fundamental weakness but potential regulatory tailwinds.
TXG trades at $58.57, up 12.57% in 24 hours, reflecting strong momentum. The stock is technically bullish with moving averages supporting the uptrend, though RSI levels suggest overbought conditions. Fundamentally, the company shows improving trends with Q2 2026 earnings beating estimates and revenue growth, yet remains unprofitable with a negative net income margin. Recent news highlights collaborations and acquisitions expanding its genomic capabilities.
Outlook is mixed; analyst consensus is neutral with a $46 price target below current levels, indicating caution despite recent beats. Key risks include sustained losses and competitive pressures, but operational cash flow growth and strategic expansions offer potential upside for patient investors focused on long-term biotech innovation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About SMX Security Matters plc
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
